Literature DB >> 2232709

Human MCTC type of mast cell granule: the uncommon occurrence of discrete scrolls associated with focal absence of chymase.

S S Craig1, L B Schwartz.   

Abstract

Two types of mast cells were previously defined based on neutral protease composition and ultrastructurally distinguished by granule morphology. The MCT cell contains tryptase with little, if any, chymase and was noted to have varying numbers of irregularly-shaped granules with discrete scrolls or particulate or beaded material. The MCTC cell contains both tryptase and chymase and was noted to have more regularly-shaped electron-dense granules with characteristic grating or lattice substructures. This study reports the use of electron microscopy and immunogold staining with antibodies against tryptase and chymase to demonstrate in mature unstimulated MCTC cells in situ, the focal occurrence of discrete or complete scrolls in peripheral regions of certain granules where chymase is deficient. these scrolls often appeared to be protruding from the granule. Granules containing discrete scrolls were observed in 10 of 340 mature MCTC cells, accounting for less than 1% of MCTC granules. Other granules in such cells as well as other regions of the granule under consideration, showed strong staining for both tryptase and chymase. These results strengthen the association of morphology with protease composition in human mast cell secretory granules, but weaken the use of morphology alone to identify the MCTC and MCT types of human mast cells. Whether the uncommon occurrence of focal absence of chymase in MCTC cells arises by chance or as a result of factors relating to mast cell development, interconversion, activation, or regranulation will require further clarification. In conclusion, the appearance of grating or lattice structures in mast cells indicates the presence of chymase and tryptase, characteristic of the MCTC phenotype, whereas multiple discrete scrolls in irregularly shaped granules suggests the MCT phenotype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2232709

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  Characterization of human mast cells developed in vitro from fetal liver cells cocultured with murine 3T3 fibroblasts.

Authors:  A A Irani; S S Craig; G Nilsson; T Ishizaka; L B Schwartz
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

Review 2.  Tryptase as a polyfunctional component of mast cells.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Vera Samoilova; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2018-03-12       Impact factor: 4.304

3.  Mast cell tryptase and chymase in developing and mature psoriatic lesions.

Authors:  I T Harvima; A Naukkarinen; K Paukkonen; R J Harvima; M L Aalto; L B Schwartz; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

Review 4.  Mast cell proteinases and cytokines in skin inflammation.

Authors:  I T Harvima; L Horsmanheimo; A Naukkarinen; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  Activation of Eosinophils and Mast Cells in Functional Dyspepsia: an Ultrastructural Evaluation.

Authors:  Hanne Vanheel; Maria Vicario; Werend Boesmans; Tim Vanuytsel; Eloisa Salvo-Romero; Jan Tack; Ricard Farré
Journal:  Sci Rep       Date:  2018-03-29       Impact factor: 4.379

6.  Effects of mitomycin C on the expression of chymase and mast cells in the conjunctival scar of a monkey trabeculectomy model.

Authors:  Kouhei Okada; Tetsuya Sugiyama; Shinji Takai; Denan Jin; Osamu Ishida; Masanori Fukmoto; Hidehiro Oku; Mizuo Miyazaki; Tsunehiko Ikeda
Journal:  Mol Vis       Date:  2009-10-13       Impact factor: 2.367

Review 7.  Mast cells as a potential prognostic marker in prostate cancer.

Authors:  Gianluigi Taverna; Guido Giusti; Mauro Seveso; Rodolfo Hurle; Piergiuseppe Colombo; Sanja Stifter; Fabio Grizzi
Journal:  Dis Markers       Date:  2013-11-11       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.